Ark Invest analyst Ali Urman compares Covid-19 vaccines from John and Johnson, Pfizer, and Moderna and others. She says Johnson and Johnson said that we will likely see data by the end of January with their earnings call coming up and it may come up there. There is also a 50 percent threshold for the efficacy for the vaccine and Ali is hoping for a 80 to 95 percent efficacy.
25 Jan 2021
The Watch List
24 Nov 2021
Trading 360
02 Nov 2021
Morning Trade Live
04 Nov 2021
Trading 360
22 Nov 2021
Trading 360
21 Dec 2021
Futures
30 Nov 2021